Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Bita Shahrami"'
Autor:
Parinaz Sadat Mahmoudi, Romina Kaveh-Ahangaran, Tahereh Rostami, Ashraf Sadat Hosseini, Mohammad Vaezi, Bita Shahrami
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-7 (2024)
Abstract Background Allogeneic hematopoietic stem cell transplantation is a definitive cure for eligible patients with thalassemia major, and calcineurin inhibitors are essential for preventing graft-versus-host disease. Although invaluable, there ar
Externí odkaz:
https://doaj.org/article/ba9aa9b03d9f416db688e0571056b908
Autor:
Shima Heidari, Mahsa Panahishokouh, Davoud Babakhani, Sohrab Aghabeigi, Mohammad Vaezi, Shahideh Amini, Molouk Hadjibabaie, Bita Shahrami
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 363-371 (2023)
Vincristine (VCR) as a key drug for the treatment of acute lymphoblastic leukemia (ALL) is associated with neurotoxicity. We present a young man with a history of controlled childhood seizures who was diagnosed with pre-B-cell ALL and developed gener
Externí odkaz:
https://doaj.org/article/fed4a49a08b544b0a3f8929263c52b19
Autor:
AmirAhmad Arabzadeh, Elnaz Faghfuri, Saiedeh Razi Soofiyani, Elaheh Dalir Abdolahinia, Samaneh Siapush, Kazem Nejati-Koshki, Bita Shahrami, Vahid Asghariazar, Yasamin Pahlavan
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 13, Iss 2, Pp 259-268 (2023)
Despite the improvements in endovascular techniques during the last decades, there is still an increase in the prevalence of peripheral artery disease (PAD) with limited practical treatment, which timeline impact of any intervention for critical limb
Externí odkaz:
https://doaj.org/article/f793f11f97b647dc97620ab04ced6d01
Autor:
Bita Shahrami, Farhad Najmeddin, Mohammad Reza Rouini, Atabak Najafi, Kourosh Sadeghi, Shahideh Amini, Seyedeh Sana Khezrnia, Hamid Reza Sharifnia, Mojtaba Mojtahedzadeh
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 10, Iss 1, Pp 114-118 (2020)
Purpose: Although the current widespread use of amikacin is in intra-abdominal sepsis treatment, its pharmacokinetic changes in the present setting are not yet well known. This study was aimed to evaluate the amikacin pharmacokinetic profile in criti
Externí odkaz:
https://doaj.org/article/48e27a37df4d4801b153ccb7430a84cf
Autor:
Seyedeh Sana Khezrnia, Bita Shahrami, Mohammad Reza Rouini, Atabak Najafi, Hamid Reza Sharifnia, Sima Sadrai, Arezoo Ahmadi, Aarefeh Jafarzadeh kohneloo, Farhad Najmeddin, Mojtaba Mojtahedzadeh
Publikováno v:
Acta Medica Iranica, Vol 60, Iss 1 (2022)
Phenobarbital is still one of the drugs of choice in managing patients with brain injury in the intensive care unit (ICU). However, the impact of acute physiological changes on phenobarbital pharmacokinetic parameters is not well studied. This study
Externí odkaz:
https://doaj.org/article/84dbeb4f783640a99426394b626b9e08
Autor:
Bita Shahrami, Effat Davoudi-Monfared, Zahra Rezaie, Shayesteh Gheibi, Ayda Vakili-Ardabili, Amir Ahmad Arabzadeh, Ali Talebi, Mojtaba Mojtahedzadeh
Publikováno v:
Respiratory Medicine Case Reports, Vol 36, Iss , Pp 101611- (2022)
A 78-year-old man with COVID-19 infection was admitted. Initial echocardiography indicated left ventricular ejection fraction (LVEF) of 15%, high pulmonary arterial pressure, severe left ventricular dysfunction, mild diastolic dysfunction, mild regur
Externí odkaz:
https://doaj.org/article/dcfbd2f16d9740fc8653ec0d99bd6c5a
Autor:
Farzaneh Jamali, Bita Shahrami, Amirmahdi Mojtahedzadeh, Farhad Najmeddin, Amir Ahmad Arabzadeh, Azar Hadadi, Mohammad Sharifzadeh, Mojtaba Mojtahedzadeh
Publikováno v:
Journal of Lipids, Vol 2022 (2022)
This pilot study aimed to determine early changes of LXA4 levels among the hospitalized patients confirmed as COVID-19 cases following the clinical management and its correlation with commonly used inflammatory markers, including erythrocyte sediment
Externí odkaz:
https://doaj.org/article/221c79a6c18243cd8aa1815f6fdaade1
Autor:
Afsaneh Sadremomtaz, Javad Hashemi, Adeleh Sahebnasagh, Seyed Mohammad Nabavi, Zayana M.Al-Dahmani, Shayesteh Gheibi, Bita Shahrami, Reza Mosaed, Peyman Arfa, Soheil Roshanzamiri, Mojtaba Mojtahedzadeh
Publikováno v:
Archives of Anesthesia and Critical Care, Vol 7, Iss 4 (2021)
At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality am
Externí odkaz:
https://doaj.org/article/64f1d131ed344f4884542650026be316
Publikováno v:
Journal of Pharmaceutical Care, Vol 8, Iss 3 (2020)
A new corona virus disease (COVID-19) is affected more than 5 million people worldwide to date and has become a global pandemic. Since there is no definitive cure for this life threatening disease, many clinical studies are underway in this regard. P
Externí odkaz:
https://doaj.org/article/ad805e4bb0e34e2d90fe6d908d2c11d1
Autor:
Mohammadreza Rouini, Niloofar Khoshnam Rad, Mojtaba Mojtahedzadeh, Atabak Najafi, Hamidreza Sharifnia, Mehrnoush Dianatkhah, Farhad Najmeddin, Ali Mohammad Hadi, Bita Shahrami
Publikováno v:
Journal of Pharmaceutical Care, Vol 8, Iss 1 (2020)
Background: Intracranial hemorrhage (ICH) is a devastating condition with a high mortality and morbidity rate. Neuroprotective agents protect surrounding brain tissue from the toxic effects of hematoma and can result in better outcomes. There is evid
Externí odkaz:
https://doaj.org/article/dd6ee132f93146b1abbfbefe156d574f